BMJ8d
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Correspondence to Martin Aringer, Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden D-01307, Germany; martin.aringer{at}uniklinikum-dresden.de; Dr ...
BMJ4d
Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake
A clinical guideline is a document with the aim of guiding decisions based on evidence regarding diagnosis, management and treatment in specific areas of healthcare. Specific to rheumatic and ...
BMJ8d
Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis
1 Rheumatology Section, The Eric Bywaters Centre, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK 2 Department of Nuclear Medicine, Faculty of Medicine, Imperial ...
BMJ5d
Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery
OBJECTIVES To determine whether continued methotrexate treatment increases the risk of postoperative infections or of surgical complications in patients with rheumatoid arthritis (RA) within one year ...
BMJ6d
OP0132 TREAT-TO-TARGET APPROACH ALLOWS TO INDUCE SUSTAINED CLINICAL REMISSION IN OVER 60% OF PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS
Background: Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission. However, such studies are difficult to conduct in axial ...
BMJ8d
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ6d
POS0803 VUNAKIZUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLIND, ADAPTIVE, SEAMLESS, PHASE 2/3 STUDY
3 The First Affiliated Hospital of Guangxi Medical University, NanNing, China 4 The Second Affiliated Hospital of Guangxi Medical University, NanNing, China 5 The First Affiliated Hospital of ...
BMJ4d
The genetic basis of spondyloarthritis
Modern technological innovations have advanced our understanding of the genetic basis of spondyloarthritis. In ankylosing spondylitis (AS), where the major histocompatibility complex (MHC) accounts ...
BMJ5d
OP0027 Abnormal B Cell Activation through Cellular Metabolic Reprogramming and Its Relevance To The Pathogenesis of SLE
Background B cells play a pivotal role in autoimmune diseases. In SLE, IFN signature is displayed and aberrant function of Toll-like receptors (TLR) for recognizing nucleic acids contributes to its ...
BMJ6d
POS0419 THE ROLE OF OROSOMUCOID 2 IN THE REGULATION OF BONE REMODELING BY INHIBITING OSTEOCLASTOGENESIS AND PROMOTING OSTEOGENESIS
1 Wonkwang University Medical School, Internal Medicine, Iksan, Korea, Rep. of (South Korea) 2 Jeonbuk National University Medical School, Internal Medicine, Jeonju, Korea, Rep. of (South Korea) ...
BMJ6d
AB0267 BODY COMPOSITION IN PATIENTS WITH RHEUMATOID ARTHRITIS
Background: Rheumatoid arthritis (RA) is a complex inflammatory disease that modifies body composition. Using the dual-energy x-ray absorptiometry (DXA) in RA patients could be a method for body ...
BMJ7d
AB1727 SERUM AND RENAL JANUS KINAS 3 EXPRESSION IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS
Background: Imbalance between pro and anti-inflammatory cytokines is an important feature in the pathogenesis of juvenile systemic lupus erythematosus (JSLE). Janus kinases (JAKs) play an important ...